Experimental Alzheimer's Drug Halted
Myriad Genetics is halting work on its experimental Alzheimer's disease drug Flurizan after disappointing study results.
Myriad Genetics is halting work on its experimental Alzheimer's disease drug Flurizan after disappointing study results.
